Metastatic breast cancer patients with elevated circulating tumor cells do not benefi

[News]

For women with metastatic breast cancer who had elevated amounts of circulating tumor cells (CTCs) in their blood after a first line of chemotherapy, switching immediately to a different chemotherapy did not improve overall survival or time to progression, according to the results of a phase III clinical trial presented at the 2013 San Antonio Breast Cancer Symposium.

More... (http://www.medicalnewstoday.com/releases/270214.php)

['lizbeth]

Another study that could benefit from the use of functional profiling before and during the study.

By utilizing this I suspect the time of disease free progression, overall survival, and identification of which women would benefit from a change could have improved.